Niall O'Donnell - Profile and Investment Details

Investor Profile

Niall O'Donnell is a Venture Capital, Private Equity Firm based in Encinitas, California, United States with a diverse investment portfolio that includes companies such as Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix, Standard Bariatrics, Smart Wires, Amplyx Pharmaceuticals, Arch Oncology, Venture Med Group, Auxeris Therapeutics, Kereos, Mirum Pharmaceuticals, InterVene, Conforma Therapeutics, Tryton Medical, Salient Surgical Technologies, Adarza BioSystemsExcaliard Pharmaceuticals, MacroGenics, CardiaLen, Allakos, ZS Pharma, Accumetrics, Securus Medical Group, IDEV Technologies, Tioma Therapeutics, Reneo Pharmaceuticals, NexRay, Cabrellis Pharmaceuticals, Good Therapeutics, Xilio Therapeutics, Avalyn Pharma, Scout Bio, Lyric Pharmaceuticals, Calypso Medical, Velocimed, Lumena Pharmaceuticals, Otonomy, Neuros Medical, . Over time, Niall O'Donnell has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Niall O'Donnell is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Life Science, Biotechnology, Clinical Trials, Health Diagnostics, Medical, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Niall O'Donnell, as their portfolio suggests a familiarity and interest in this area.

Understanding Niall O'Donnell’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.